379 related articles for article (PubMed ID: 34831055)
21. What is the role of the bone marrow microenvironment in AML?
Mulherkar N; Scadden DT
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101328. PubMed ID: 34865700
[TBL] [Abstract][Full Text] [Related]
22. Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy.
Patel SA; Dalela D; Fan AC; Lloyd MR; Zhang TY
Leuk Lymphoma; 2022 Jan; 63(1):10-18. PubMed ID: 34407733
[TBL] [Abstract][Full Text] [Related]
23. Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions.
Guarnera L; Santinelli E; Galossi E; Cristiano A; Fabiani E; Falconi G; Voso MT
Exp Hematol; 2024 Jan; 129():104118. PubMed ID: 37741607
[TBL] [Abstract][Full Text] [Related]
24. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
25. The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia.
Li Q; Wang M; Liu L
Biochem Pharmacol; 2023 Jun; 212():115539. PubMed ID: 37024061
[TBL] [Abstract][Full Text] [Related]
26. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
28. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
29. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
Front Immunol; 2021; 12():756231. PubMed ID: 34867994
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
31. Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.
Çelik H; Lindblad KE; Popescu B; Gui G; Goswami M; Valdez J; DeStefano C; Lai C; Thompson J; Ghannam JY; Fantoni G; Biancotto A; Candia J; Cheung F; Sukumar G; Dalgard CL; Smith RH; Larochelle A; Dillon LW; Hourigan CS
Blood Adv; 2020 Jan; 4(2):367-379. PubMed ID: 31985806
[TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
34. The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia.
Allert C; Müller-Tidow C; Blank MF
Int J Cancer; 2024 Jan; 154(2):197-209. PubMed ID: 37565773
[TBL] [Abstract][Full Text] [Related]
35. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
36. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.
Boyd AL; Campbell CJ; Hopkins CI; Fiebig-Comyn A; Russell J; Ulemek J; Foley R; Leber B; Xenocostas A; Collins TJ; Bhatia M
J Exp Med; 2014 Sep; 211(10):1925-35. PubMed ID: 25180064
[TBL] [Abstract][Full Text] [Related]
37. AML alters bone marrow stromal cell osteogenic commitment via Notch signaling.
Tomasoni C; Arsuffi C; Donsante S; Corsi A; Riminucci M; Biondi A; Pievani A; Serafini M
Front Immunol; 2023; 14():1320497. PubMed ID: 38111584
[TBL] [Abstract][Full Text] [Related]
38. Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging.
Duarte D; Amarteifio S; Ang H; Kong IY; Ruivo N; Pruessner G; Hawkins ED; Lo Celso C
Immunol Cell Biol; 2019 Feb; 97(2):229-235. PubMed ID: 30422351
[TBL] [Abstract][Full Text] [Related]
39. RNA trafficking by acute myelogenous leukemia exosomes.
Huan J; Hornick NI; Shurtleff MJ; Skinner AM; Goloviznina NA; Roberts CT; Kurre P
Cancer Res; 2013 Jan; 73(2):918-29. PubMed ID: 23149911
[TBL] [Abstract][Full Text] [Related]
40. Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening.
Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M
Tissue Eng Part C Methods; 2017 Feb; 23(2):72-85. PubMed ID: 28007011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]